Insulin resistance plays a role in many diseases. The new research provides insights into why insulin resistance appears to ...

In recent years, it’s been estimated that 10% to 28% of patients with myeloid disorders develop adult onset inflammatory and ...

These 28-week data on twice-daily ESK-001 highlight the drug’s safety and efficacy among patients with psoriasis.

A new study highlights risk factors for hospitalization and severe illness among adults with respiratory syncytial virus (RSV ...

Increased time spent on discussing testing for colorectal cancer (CRC) was associated with patient satisfaction in older ...

The extent to which certified community behavioral health clinic expansion reaches different parts of the country remained ...

Initial evidence suggests alternative approaches such as exercise, dietary modification, and psychosocial therapies may ...

The approval came days before the FDA’s expected deadline and makes this the only PD-1 inhibitor approved for resectable ...

Most patients diagnosed with chronic-phase chronic myeloid leukemia (CP-CML) who achieved a deep molecular response on ...

The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years.

Panelists discuss how immunotherapies like durvalumab and atezolizumab have emerged as promising treatments for ...

On September 20, the FDA approved isatuximab plus bortezomib, lenalidomide, and dexamethasone in the first line for patients ...